Loading…
Artemis Medicare Services (ARTEMISMED)₹308.45−2.37%Hospital
In the Sep 2026 quarter (consolidated), Artemis Medicare Services reported sales of ₹311 Cr, up 13.2% from Sep 2025, and net profit of ₹31.04 Cr, up 3.3% year on year. For the year to Mar 2026, sales were ₹1,079 Cr and net profit ₹104 Cr.
Company filings, consolidated accounts; latest reported quarter Sep 2026
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 219 | 225 | 223 | 241 | 232 | 240 | 255 | 275 | 272 | 279 | 286 | 311 |
| Expenses | 186 | 186 | 187 | 199 | 195 | 204 | 214 | 224 | 227 | 227 | 231 | 255 |
| Operating Profit | 32.93 | 37.91 | 35.90 | 41.91 | 36.93 | 35.92 | 40.93 | 50.92 | 44.91 | 51.90 | 55.88 | 54.90 |
| OPM % | 15.0% | 17.0% | 16.0% | 18.0% | 16.0% | 15.0% | 16.0% | 18.0% | 16.0% | 18.0% | 20.0% | 18.0% |
| Other Income | 1.99 | 1.99 | 3.99 | 6.98 | 8.97 | 11.97 | 6.98 | 7.98 | 3.99 | 7.98 | 4.98 | 7.97 |
| Interest | 8.01 | 9.01 | 8.01 | 8.02 | 8.01 | 8.02 | 7.01 | 7.01 | 7.01 | 6.01 | 6.01 | 7.01 |
| Depreciation | 9.96 | 10.96 | 10.96 | 10.95 | 10.95 | 11.95 | 10.95 | 11.95 | 11.96 | 12.94 | 12.95 | 13.94 |
| Profit before tax | 16.03 | 20.02 | 22.03 | 31.05 | 27.01 | 29.04 | 30.04 | 39.02 | 30.05 | 40.03 | 43.04 | 41.04 |
| Tax % | 29.1% | 29.0% | 24.1% | 28.1% | 23.1% | 20.0% | 29.1% | 24.1% | 25.1% | 25.1% | 26.1% | 24.1% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −2.31 | 0.00 | 0.00 | 0.00 |
| Net Profit | 12.03 | 14.03 | 17.03 | 22.05 | 21.04 | 23.05 | 21.04 | 30.06 | 22.03 | 30.06 | 31.03 | 31.04 |
| EPS (Rs) | 0.86 | 1.05 | 1.23 | 1.63 | 1.51 | 1.68 | 1.54 | 2.17 | 1.42 | 1.91 | 1.99 | 1.97 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 546 | 565 | 407 | 554 | 735 | 878 | 935 | 1,079 | 1,147 |
| Expenses | 480 | 502 | 372 | 486 | 642 | 744 | 783 | 890 | 941 |
| Operating Profit | 65.81 | 61.90 | 34.95 | 67.91 | 93.76 | 133 | 152 | 188 | 208 |
| OPM % | 12.0% | 11.0% | 9.0% | 12.0% | 13.0% | 15.0% | 16.0% | 17.0% | 18.1% |
| Other Income | 1.99 | 3.99 | 6.98 | 2.99 | 6.98 | 6.98 | 32.92 | 26.92 | 24.92 |
| Interest | 11.01 | 13.01 | 13.01 | 12.01 | 20.02 | 31.03 | 32.07 | 28.05 | 26.04 |
| Depreciation | 19.91 | 22.90 | 21.90 | 21.92 | 30.85 | 39.87 | 44.83 | 47.78 | 51.79 |
| Profit before tax | 37.04 | 31.06 | 8.02 | 37.05 | 51.09 | 68.08 | 108 | 139 | 154 |
| Tax % | 45.0% | 36.1% | 18.1% | 16.1% | 25.0% | 28.0% | 24.0% | 25.1% | — |
| Exceptional items | −1.01 | 0.00 | 0.00 | 0.00 | 1.01 | 0.00 | 0.00 | −2.01 | −2.31 |
| Net Profit | 20.02 | 19.03 | 6.01 | 31.07 | 38.04 | 49.12 | 82.19 | 104 | 114 |
| EPS (Rs) | 0.98 | 1.50 | 0.50 | 2.41 | 2.89 | 3.64 | 6.02 | 6.58 | 7.29 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 16.0% | 12.1% | 7.0% | 7.0% | — |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 13.04 | 13.05 | 13.03 | 13.03 | 13.03 | 14.06 | 14.03 | 16.05 |
| Reserves | 280 | 300 | 307 | 346 | 390 | 435 | 824 | 919 |
| Borrowings | 114 | 113 | 147 | 201 | 287 | 321 | 291 | 263 |
| Other Liabilities | 146 | 159 | 132 | 148 | 215 | 202 | 228 | 231 |
| Total Liabilities | 554 | 586 | 600 | 710 | 905 | 972 | 1,356 | 1,428 |
| Fixed Assets | 382 | 393 | 383 | 489 | 605 | 720 | 746 | 805 |
| CWIP | 48.93 | 55.93 | 80.88 | 63.95 | 94.95 | 32.98 | 39.96 | 28.99 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 124 | 137 | 135 | 157 | 204 | 218 | 570 | 594 |
| Inventories | 6.98 | 10.96 | 9.96 | 11.96 | 13.96 | 9.98 | 9.97 | 12.97 |
| Trade receivables | 79.01 | 76.99 | 55.07 | 73.03 | 92.99 | 94.99 | 101 | 120 |
| Cash & equivalents | 12.01 | 16.01 | 31.03 | 28.03 | 51.10 | 61.08 | 397 | 206 |
| Total Assets | 554 | 586 | 600 | 710 | 905 | 972 | 1,356 | 1,428 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 39.94 | 55.90 | 26.97 | 59.87 | 127 | 109 | 156 | 132 |
| Cash from investing activity | −50.19 | −26.09 | −37.17 | −107 | −159 | −88.39 | −395 | −90.33 |
| Cash from financing activity | 13.97 | −26.95 | 17.97 | 43.90 | 37.93 | −28.96 | 264 | −49.88 |
| Net cash flow | 5.01 | 1.99 | 7.99 | −3.01 | 6.99 | −7.99 | 26.99 | −7.99 |
| Capex | 57.25 | 26.09 | 34.10 | 109 | 147 | 73.29 | 93.38 | 105 |
| Free cash flow | −17.01 | 29.98 | −4.01 | −48.97 | −18.02 | 37.01 | 64.99 | 31.99 |
| CFO / OP % | 76.0% | 97.9% | 82.9% | 63.0% | 137.9% | 94.0% | 112.0% | 79.0% |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Debtor days | 52 | 49 | 49 | 48 | 46 | 39 | 39 | 40 |
| Cash conversion cycle | 51 | 48 | 48 | 47 | 45 | 38 | 38 | 39 |
| Working capital days | −50 | −35 | −35 | −25 | −42 | −26 | −29 | −16 |
| ROCE % | — | 10.0% | 4.0% | 10.0% | 11.0% | 13.9% | 14.9% | 15.0% |
For the Sep 2026 quarter, Artemis Medicare Services reported sales of ₹311 Cr, up 13.2% year on year and net profit of ₹31.04 Cr, up 3.3% year on year. The operating margin was 18.0%.
Artemis Medicare Services' sales for the year to Mar 2026 were ₹1,079 Cr; over the last twelve months they were ₹1,147 Cr.
Net profit for the year to Mar 2026 was ₹104 Cr, and ₹114 Cr over the last twelve months. Earnings per share over the same trailing period were ₹7.29.
Artemis Medicare Services reported borrowings of ₹263 Cr at Mar 2026, against cash and equivalents of ₹206 Cr.
Cash from operations was ₹132 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹31.99 Cr.